In recent years, the use of nucleic acid-based drugs to treat and prevent diseases has become increasingly important. Last year, two nanovaccines based on synthetic messenger RNAs (mRNAs) encoding viral proteins were approved by the FDA against COVID-19, successfully demonstrating the applicability of synthetic mRNAs for infectious disease prevention